Disclosure of autoimmune hepatitis by interferon
Payen, J.L.; Rabbia, I.; Combis, M.; Voigt, J.J.; Vinel, P.; Pascal, J.P.
Gastroenterologie Clinique et Biologique 17(5): 404-405
1993
ISSN/ISBN: 0399-8320 PMID: 8349084 Document Number: 414771
Document emailed within 1 workday
Related Documents
Kaji, K.; Unoura, M.; Kobayashi, K.; Nakanuma, Y. 1994: Autoimmune hepatitis with hepatitis C virus markers (anti HCV antibody or HCV-RNA) and interferon therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 52(7): 1865-1868Ozaslan, E.; Efe, C.; Akbulut, S.; Purnak, T.; Savas, B.; Erden, E.; Altiparmak, E. 2010: Therapy response and outcome of overlap syndromes: autoimmune hepatitis and primary biliary cirrhosis compared to autoimmune hepatitis and autoimmune cholangitis Hepato-Gastroenterology 57(99-100): 441-446
Ettinger, O.A.; Nikitin, I.G.; Storozhakov, G.I. 1999: Autoimmune lesions of thyroid as complications of interferon treatment of chronic viral hepatitis Terapevticheskii Arkhiv 71(12): 69-72
Gschwantler, M.; Schrutka-Kölbl, C.; Weiss, W. 1995: Acute exacerbation of antiliver cytosol antibody-positive autoimmune chronic hepatitis by alpha-interferon American Journal of Gastroenterology 90(12): 2239-2240
Rocco, A.; Gargano, S.; Provenzano, A.; Nardone, M.; De Sanctis, G.M.; Altavilla, N.; Chircu, L.V.; Grimaldi, F. 2001: Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection Neuro Endocrinology Letters 22(1): 39-44
Hrycewycz, N.; Sandres, K.; Barange, K.; Pascal, J.P.; Izopet, J.; Payen, J.L. 2001: Eradication of hepatitis C virus after 3 months of interferon and ribavirin treatment in an a interferon non-responder patient with chronic hepatitis C Gastroenterologie Clinique et Biologique 25(11): 1041-1042
Giannoccaro, F.; Pace, L.; Antonaci, S.; Schiraldi, O. 1999: Autoimmune hemolytic anemia in chronic hepatitis C virus infection treated with alpha-interferon: a therapy-related event or extra-hepatic immunologic manifestation? Recenti Progressi in Medicina 90(11): 592-594
Bojić, I. 1997: Autoimmune hepatitis and autoimmune manifestations in patients with chronic viral hepatitis Medicinski Pregled 50(9-10): 363-368
Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908
Sakuma, I.; Enomoto, N.; Asahina, Y.; Kurosaki, M.; Sato, C. 1995: Fluctuation of hepatitis C virus quasispecies with interferon treatment and interferon-resistant variants in hepatitis C virus 1b Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Suppl (Part 1): 930-935
Moccia, F.; Tognoni, E.; Boccaccio, P. 2001: Autoimmune hemolytic anemia in chronic hepatitis C virus infection: an unusual extrahepatic autoimmune manifestation Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 16(4): 256-259
Mels, G.C.; Roffi, L.; Antonelli, G.; Bellati, G.; Pacchetti, S.; Di Nolfo, M.A.; Panizzuti, F.; Moretti, G.; Piperno, A.; Pozzi, M. 1993: Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy Progress in Clinical and Biological Research 382: 359-364
Ali, S.; Nazir, G.; Khan, S.A.; Iram, S.; Fatima, F. 2010: Comparative therapeutic response to pegylated interferon plus ribavirin versus interferon alpha-2b in chronic hepatitis C patients Journal of Ayub Medical College Abbottabad: Jamc 22(4): 127-130
Musch, E.; Högemann, B.; Gerritzen, A.; Fischer, H.P.; Wiese, M.; Kruis, W.; Malek, M.; Gugler, R.; Schmidt, G.; Huchzermeyer, H.; Gerlach, U.; Dengler, H.J.; Sauerbruch, T. 1998: Phase Ii clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B Hepato-Gastroenterology 45(24): 2282-2294
Rodrigo Sáez, L.; Vivas Alegre, S.; Palacio Galán, M.A.; Pérez Alvarez, R.; Rodríguez García, M. 1997: Associated autoimmune hepatitis and chronic hepatitis C virus infection: diagnostic and therapeutic criteria Gastroenterologia y Hepatologia 20(1): 43-44
Nishiguchi, S.; Kuroki, T.; Ueda, T.; Fukuda, K.; Takeda, T.; Nakajima, S.; Shiomi, S.; Kobayashi, K.; Otani, S.; Hayashi, N. 1992: Detection of hepatitis C virus antibody in the absence of viral RNA in patients with autoimmune hepatitis Annals of Internal Medicine 116(1): 21-25
Antonaci, S.; Giannelli, G.; Simone, B.; Vella, F.S. 2005: Syndrome of overlap: Chronic hepatitis C/autoimmune hepatitis: fact or fancy? Recenti Progressi in Medicina 96(1): 27-31
Vella, F.Saverio.; Simone, B.; Orlando, P.; Simone, O.; Antonaci, S. 2004: Chronic hepatitis C/autoimmune hepatitis overlap syndrome: report of two cases Recenti Progressi in Medicina 95(10): 472-475
Nasonov, E.L.; Burlev, V.A.; Golosova, T.V.; Speranskiĭ, A.I.; Somova, A.V. 1977: Autoimmune component in chronic active hepatitis and its connection with isolation of the hepatitis B surface antigen Terapevticheskii Arkhiv 49(6): 84-89
Lobello, S.; Lorenzoni, U.; Vian, A.; Floreani, A.; Brunetto, M.R.; Chiaramonte, M. 1998: Interferon treatment in hepatitis B surface antigen-positive hepatitis B e antibody-positive chronic hepatitis B: role of hepatitis B core antibody IgM titre in patient selection and treatment monitoring Journal of Viral Hepatitis 5(1): 61-66